The Centers for Disease Control and Prevention (CDC) recommends LTBI screening in individuals at increased risk of reactivation to active TB disease, such as close contacts of newly diagnosed TB patients, individuals with comorbidities, and those planning to start immunosuppressive medications such as tumor necrosis factor alpha (TNF-α) blockers or biologics (5). Here, TNF is linked to tuberculosis.